| The report from the Food and Drug administration comes ahead of a key FDA committee meeting Friday to review Johnson & Johnson's COVID-19 vaccine, which will clear the way for its expected authorization. It will be the third vaccine allowed in the US against the coronavirus, and the only one that calls for just one dose. |  |
News Alert Wednesday, February 24 |
|
| | | | | | | | |
|
